Clinical Trial Update: WT1 for the Detection of Minimal Residual Disease [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for detecting minimal residual disease using WT1 in leukemia, with Phase 2/Phase 3 studies completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Leukemia, Cancer | Phase 2, Phase 3 | Status: COMPLETED